--- title: "歐洲股票作為美國存託憑證在美國交易,週二交易中呈現下跌趨勢" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/286941247.md" description: "在美國交易的歐洲股票以美國存託憑證形式下跌 0.3%,報 1,824.16 點,位於標準普爾歐洲精選 ADR 指數上。顯著上漲的公司包括 SAP(+5.3%)和 Criteo(+3.6%),而 Sequans Communications(-3.5%)和諾基亞(-2.7%)則位於下跌榜單中。在英國,Akari Therapeutics(+4.9%)和 NuCana(+3.5%)上漲,而 Autolus Therapeutics(-8%)則領跌" datetime: "2026-05-19T15:27:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286941247.md) - [en](https://longbridge.com/en/news/286941247.md) - [zh-HK](https://longbridge.com/zh-HK/news/286941247.md) --- # 歐洲股票作為美國存託憑證在美國交易,週二交易中呈現下跌趨勢 11:27 AM EDT, 05/19/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.3% to 1,824.16 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by software firm SAP (SAP) and internet advertising company Criteo ( CRTO ) , which advanced 5.3% and 3.6% respectively. They were followed by biopharmaceutical company argenx (ARGX) and petroleum refiner Equinor ( EQNR ) , which rose 2.1% and 1.3% respectively. The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and telecommunications company Nokia ( NOK ) , which dropped 3.5% and 2.7% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and medical device maker EDAP TMS ( EDAP ) , which were off 2.6% and 1.6% respectively. The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which were up 4.9% and 3.5% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and medical device company Smith & Nephew ( SNN ) , which were up 3.1% and 2.6% respectively. The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) , which fell 8%, followed by mining company BHP Group ( BHP ) and pharmaceutical company Silence Therapeutics ( SLN ) , which lost 3% and 0.6% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### 相關股票 - [SAP.DE](https://longbridge.com/zh-HK/quote/SAP.DE.md) - [SAP.US](https://longbridge.com/zh-HK/quote/SAP.US.md) - [SQNS.US](https://longbridge.com/zh-HK/quote/SQNS.US.md) - [NOK.US](https://longbridge.com/zh-HK/quote/NOK.US.md) ## 相關資訊與研究 - [SAP 人工智能路線圖未能提振股價,Sapphire 大會令投資者失望](https://longbridge.com/zh-HK/news/286306302.md) - [SAP 的 “諾基亞時刻”,真的來了](https://longbridge.com/zh-HK/news/286979806.md) - [《大手成交》阿里等 2 家公司上午 9:04 市前大手交易](https://longbridge.com/zh-HK/news/286835406.md) - [去年標案、企業 AI 基建挹注 華電聯網今年下半年營運拚轉強](https://longbridge.com/zh-HK/news/286406310.md) - [五年前投資 100 美元在諾基亞的價值今天是多少](https://longbridge.com/zh-HK/news/286963594.md)